|
Iborra-Egea O, Santiago-Vacas E, Yurista SR, Lupon J, Packer M, Heymans S, Zannad F, Butler J, Pascual-Figal D, Lax A, Nunez J, de Boer RA, Bayes-Genis A. Unraveling the Molecular Mechanism of Action of Empagliflozin in Heart Failure With Reduced Ejection Fraction With or Without Diabetes. JACC Basic Transl Sci. 2019 Oct 23;4(7):831-840. doi: 10.1016/j.jacbts.2019.07.010. eCollection 2019 Nov. PubMed PMID: 31998851; PubMed Central PMCID: PMC6978551.
AÑO: 2019; IF: 8.648
|
|
Lopez, MCA; Lopez-Herrera, P; Oltra-Rodriguez, L; Garcia-Carrillo, N; Saura-Guillen, E; Hernandez-Vicente, A; Sanchez-Perez, MCA; Fernandez-Villa, N; Pascual-Figal, DA; Lax, AMAM. Empagliflozin modulates GTP enzyme cyclohydrolase 1 in chronic heart failure. EUROPEAN JOURNAL OF HEART FAILURE. 2019; 21:320-320.
AÑO: 2019; IF: 11.627
|
|
Garcia-Pavia P, Kim Y, Restrepo-Cordoba MA, Lunde IG, Wakimoto H, Smith AM, Toepfer CN, Getz K, Gorham J, Patel P, Ito K, Willcox JA, Arany Z, Li J, Owens AT, Govind R, Nunez B, Mazaika E, Bayes-Genis A, Walsh R, Finkelman B, Lupon J, Whiffin N, Serrano I, Midwinter W, Wilk A, Bardaji A, Ingold N, Buchan R, Tayal U, Pascual-Figal DA, de Marvao A, Ahmad M, Garcia-Pinilla JM, Pantazis A, Dominguez F, John Baksi A, O'Regan DP, Rosen SD, Prasad SK, Lara-Pezzi E, Provencio M, Lyon AR, Alonso-Pulpon L, Cook SA, DePalma SR, Barton PJR, Aplenc R, Seidman JG, Ky B, Ware JS, Seidman CE. Genetic Variants Associated With Cancer Therapy-Induced Cardiomyopathy. Circulation. 2019 Jul 2;140(1):31-41. doi: 10.1161/CIRCULATIONAHA.118.037934. Epub 2019 Apr 16. PubMed PMID: 30987448; PubMed Central PMCID: PMC6613726.
AÑO: 2019; IF: 23.603
|
|
Pascual-Figal DA, Lax A, Bayes-Genis A. Reply: Interleukin-1beta and sST2. J Am Coll Cardiol. 2019 Jul 23;74(3):479-480. doi: 10.1016/j.jacc.2019.05.021. No abstract available. PubMed PMID: 31319926.
AÑO: 2019; IF: 20.589
|
|
Navarro-Penalver M, Mohamed-Salem L, Dominguez F, de Haro-Del Moral FJ, Fernandez-Lozano I, Pascual-Figal DA. Cardiac Sympathetic Innervation and Appropriate Therapies in Patients With an Implantable Cardioverter-defibrillator in Primary Prevention. Rev Esp Cardiol (Engl Ed). 2019 Feb;72(2):180-182. doi: 10.1016/j.rec.2018.01.014. Epub 2018 Apr 9. No abstract available. English, Spanish. PubMed PMID: 29650449.
AÑO: 2019; IF: 4.642
|